Perrigo (PRGO)
(Delayed Data from NYSE)
$27.13 USD
-0.64 (-2.30%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $27.14 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Perrigo Company plc [PRGO]
Reports for Purchase
Showing records 1 - 20 ( 373 total )
Company: Perrigo Company plc
Industry: Medical - Products
Optimized Entry and Exit Levels for PRGO 091424
Provider: Stock Traders Daily
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Perrigo Company plc
Industry: Medical - Products
Optimized Entry and Exit Levels for PRGO 21224
Provider: Stock Traders Daily
Analyst: Research Department